Assessing AnaptysBio (ANAB) Valuation After New US$100 Million Buyback And Cancelled Equity Offerings [Yahoo! Finance]
AnaptysBio, Inc. (ANAB)
Last anaptysbio, inc. earnings: 3/2 08:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.anaptysbio.com/investor-relations
Company Research
Source: Yahoo! Finance
Why AnaptysBio's capital moves matter for existing shareholders AnaptysBio (ANAB) recently paired a new share repurchase program of up to US$100 million with the withdrawal of two planned at the market equity offerings, a combination that directly affects existing holders' ownership. By planning buybacks instead of issuing new shares, the company is signaling a preference for returning capital and avoiding dilution. Investors are weighing how this approach fits alongside its cash position and pipeline focused business model. See our latest analysis for AnaptysBio. The share price has been firming, with a 33.52% 90 day share price return and 28.32% year to date share price return, while the 1 year total shareholder return of 211.62% highlights how quickly sentiment around AnaptysBio has shifted. After a move like this, it can be useful to compare AnaptysBio with other biotech names and see how it stacks up against 36 healthcare AI stocks With AnaptysBio trading at US$57.68
Show less
Read more
Impact Snapshot
Event Time:
ANAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANAB alerts
High impacting AnaptysBio, Inc. news events
Weekly update
A roundup of the hottest topics
ANAB
News
- AnaptysBio (ANAB) had its price target raised by Piper Sandler from $67.00 to $95.00. They now have an "overweight" rating on the stock.MarketBeat
- AnaptysBio (ANAB) had its "buy" rating reaffirmed by HC Wainwright. They now have a $66.00 price target on the stock.MarketBeat
- Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics [Yahoo! Finance]Yahoo! Finance
- Anaptys Board of Directors Approves Spin-Off of First Tracks BiotherapeuticsGlobeNewswire
- First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private PlacementGlobeNewswire
ANAB
Earnings
- 3/3/26 - Beat
ANAB
Sec Filings
- 4/3/26 - Form 3
- 4/1/26 - Form 4
- 3/30/26 - Form 144
- ANAB's page on the SEC website